Header Logo

Annabelle Santos Volgman

Concepts (370)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Atrial Fibrillation
24
2023
135
7.820
Why?
Cardiovascular Diseases
22
2024
372
5.540
Why?
Stroke
21
2023
274
4.420
Why?
Heart Failure
8
2023
179
2.590
Why?
Female
79
2024
15704
2.080
Why?
Transcatheter Aortic Valve Replacement
4
2023
20
2.010
Why?
Aortic Valve Stenosis
4
2023
23
2.000
Why?
Humans
104
2024
28395
1.990
Why?
Anticoagulants
7
2022
90
1.950
Why?
Myocardial Infarction
11
2023
145
1.810
Why?
Risk Factors
32
2024
2408
1.720
Why?
Healthcare Disparities
6
2020
85
1.710
Why?
Coronary Artery Disease
8
2022
141
1.680
Why?
Sex Factors
18
2022
475
1.620
Why?
Pregnancy Complications, Cardiovascular
6
2023
15
1.570
Why?
Hospital Mortality
8
2023
147
1.520
Why?
Cardiologists
2
2023
8
1.520
Why?
Exercise
7
2022
473
1.400
Why?
Cardiology
5
2022
57
1.390
Why?
Cognitive Dysfunction
6
2024
1065
1.340
Why?
Risk Assessment
14
2022
676
1.340
Why?
Sex Characteristics
7
2023
118
1.290
Why?
Hospitalization
8
2021
323
1.270
Why?
Women's Health
4
2020
176
1.250
Why?
Myocardial Ischemia
4
2022
43
1.230
Why?
Life Style
8
2020
201
1.230
Why?
Aged
41
2024
9256
1.180
Why?
Male
48
2023
15269
1.170
Why?
Primary Prevention
4
2022
35
1.160
Why?
Acute Kidney Injury
3
2023
47
1.160
Why?
Cardiovascular System
3
2022
15
1.150
Why?
Quality of Life
8
2023
658
1.140
Why?
United States
27
2023
2196
1.110
Why?
Physicians, Women
3
2022
17
1.100
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
4
2020
61
1.080
Why?
Pacemaker, Artificial
3
2023
22
1.050
Why?
Arrhythmias, Cardiac
6
2019
73
1.010
Why?
Catheter Ablation
3
2022
72
1.010
Why?
Angiotensin-Converting Enzyme Inhibitors
2
2020
25
0.970
Why?
Adrenergic beta-Antagonists
2
2020
29
0.960
Why?
Health Status Disparities
4
2019
74
0.950
Why?
Defibrillators, Implantable
3
2021
12
0.940
Why?
Middle Aged
33
2024
9250
0.930
Why?
Anti-Arrhythmia Agents
7
2022
37
0.920
Why?
American Heart Association
4
2023
18
0.880
Why?
Ischemic Attack, Transient
2
2023
17
0.870
Why?
Terminal Care
1
2023
27
0.820
Why?
Echocardiography, Doppler, Color
2
2019
13
0.810
Why?
Heart Defects, Congenital
1
2023
35
0.790
Why?
Myocarditis
1
2022
12
0.790
Why?
Premature Birth
1
2022
11
0.790
Why?
Electrocardiography
7
2015
119
0.760
Why?
Pregnancy
9
2023
340
0.760
Why?
Coronavirus
1
2021
2
0.740
Why?
Breast Neoplasms
3
2021
409
0.740
Why?
Length of Stay
4
2020
328
0.720
Why?
Chest Pain
1
2020
19
0.690
Why?
Brain Ischemia
1
2021
63
0.690
Why?
Intersectoral Collaboration
1
2020
7
0.690
Why?
Endothelium
1
2020
12
0.680
Why?
Vascular Diseases
1
2020
44
0.670
Why?
Social Media
1
2021
50
0.660
Why?
Patient Care Management
2
2021
19
0.660
Why?
Takotsubo Cardiomyopathy
1
2019
12
0.660
Why?
Ambulatory Care Facilities
2
2022
40
0.650
Why?
Myxoma
1
2019
4
0.650
Why?
Treatment Outcome
14
2023
3615
0.650
Why?
Cardiomyopathies
1
2019
32
0.650
Why?
Cognition
4
2024
1352
0.640
Why?
Heart Neoplasms
1
2019
13
0.640
Why?
Comorbidity
5
2021
500
0.640
Why?
Betacoronavirus
1
2020
77
0.630
Why?
Hypertension
7
2023
244
0.630
Why?
Heart Diseases
1
2020
70
0.630
Why?
Age Factors
8
2021
781
0.630
Why?
Heart Failure, Diastolic
1
2018
2
0.630
Why?
Women's Health Services
1
2018
9
0.620
Why?
Prevalence
6
2020
467
0.610
Why?
Heart Ventricles
1
2019
115
0.610
Why?
Culturally Competent Care
1
2018
11
0.600
Why?
Warfarin
3
2016
26
0.600
Why?
Delivery of Health Care, Integrated
1
2018
25
0.600
Why?
Coronavirus Infections
1
2020
90
0.600
Why?
Pneumonia, Viral
1
2020
94
0.600
Why?
Emigrants and Immigrants
1
2018
24
0.590
Why?
Antineoplastic Agents
1
2020
190
0.590
Why?
Atherosclerosis
1
2018
55
0.570
Why?
Lipoprotein(a)
1
2016
5
0.520
Why?
Prognosis
7
2021
825
0.520
Why?
Dyslipidemias
1
2016
18
0.510
Why?
Biomarkers
5
2024
596
0.500
Why?
Health Knowledge, Attitudes, Practice
2
2022
185
0.490
Why?
Diabetes Mellitus
3
2022
137
0.490
Why?
Electrodes
1
2015
12
0.490
Why?
Secondary Prevention
3
2022
54
0.480
Why?
Cost of Illness
1
2015
53
0.470
Why?
Social Support
1
2016
215
0.460
Why?
Magnetic Resonance Imaging
1
2019
1143
0.450
Why?
Adult
15
2023
8097
0.440
Why?
Electric Countershock
6
2020
11
0.440
Why?
Patient Readmission
3
2019
133
0.440
Why?
Aged, 80 and over
9
2021
4851
0.440
Why?
Aspirin
2
2020
84
0.440
Why?
Aortic Valve
3
2023
26
0.430
Why?
Non-ST Elevated Myocardial Infarction
3
2022
3
0.410
Why?
Retrospective Studies
10
2022
3609
0.410
Why?
ST Elevation Myocardial Infarction
3
2022
9
0.410
Why?
Atrial Appendage
2
2022
37
0.380
Why?
Cross-Sectional Studies
6
2024
932
0.380
Why?
Coronary Angiography
3
2020
83
0.380
Why?
Patient Acceptance of Health Care
1
2012
81
0.380
Why?
Alzheimer Disease
1
2023
2118
0.350
Why?
Frailty
2
2022
35
0.350
Why?
Cardiac Resynchronization Therapy Devices
2
2019
5
0.340
Why?
Cardiovascular Agents
2
2021
27
0.330
Why?
Hospital Costs
2
2020
64
0.330
Why?
Feasibility Studies
2
2020
231
0.320
Why?
Practice Guidelines as Topic
3
2021
320
0.310
Why?
Heart Atria
2
2019
29
0.290
Why?
Ventricular Fibrillation
2
2021
15
0.290
Why?
Percutaneous Coronary Intervention
3
2022
25
0.280
Why?
Cohort Studies
5
2023
1926
0.260
Why?
Health Status
2
2018
224
0.250
Why?
Administration, Oral
3
2016
111
0.250
Why?
Societies, Medical
3
2023
154
0.250
Why?
Randomized Controlled Trials as Topic
5
2020
329
0.250
Why?
Sex Distribution
3
2019
82
0.240
Why?
Palliative Care
2
2023
109
0.240
Why?
Antihypertensive Agents
2
2020
81
0.240
Why?
Hemorrhage
5
2020
81
0.240
Why?
Risk Adjustment
2
2021
11
0.230
Why?
Logistic Models
3
2021
395
0.230
Why?
Incidence
4
2020
773
0.220
Why?
Obesity
4
2020
321
0.220
Why?
Hospital Charges
2
2020
16
0.220
Why?
Leadership
2
2022
107
0.220
Why?
Illinois
2
2021
246
0.220
Why?
Young Adult
3
2020
2069
0.210
Why?
Cost-Benefit Analysis
2
2022
134
0.210
Why?
Cardiotoxicity
2
2020
8
0.210
Why?
Age Distribution
2
2020
89
0.210
Why?
Insulin-Like Growth Factor I
1
2024
59
0.210
Why?
Maternal Mortality
1
2023
7
0.210
Why?
Pulmonary Veins
1
2023
27
0.210
Why?
Minority Groups
1
2023
86
0.210
Why?
Morbidity
2
2019
58
0.210
Why?
Health Promotion
2
2016
162
0.210
Why?
Death
1
2023
47
0.200
Why?
Out-of-Hospital Cardiac Arrest
1
2022
8
0.200
Why?
Philippines
1
2022
4
0.200
Why?
Pregnant Women
1
2022
15
0.200
Why?
Pregnancy Outcome
1
2022
18
0.200
Why?
Cesarean Section
1
2022
30
0.200
Why?
Polypharmacy
1
2022
7
0.200
Why?
Vitamin K
1
2022
7
0.200
Why?
Attitude
1
2022
35
0.200
Why?
Sotalol
1
2021
1
0.200
Why?
Adolescent
2
2020
2307
0.190
Why?
Venous Thromboembolism
1
2022
36
0.190
Why?
Coronary Circulation
2
2020
26
0.190
Why?
Pandemics
2
2023
260
0.190
Why?
Cardiac Electrophysiology
1
2021
2
0.190
Why?
Prospective Studies
3
2023
1804
0.190
Why?
Troponin
1
2021
9
0.190
Why?
Sexism
1
2021
7
0.190
Why?
Shock, Cardiogenic
1
2021
7
0.190
Why?
Diagnostic Techniques, Cardiovascular
1
2021
3
0.190
Why?
Water-Electrolyte Imbalance
1
2021
2
0.190
Why?
Death, Sudden, Cardiac
1
2021
14
0.190
Why?
Hormones
1
2021
11
0.190
Why?
Alcohol Drinking
1
2022
80
0.180
Why?
Overweight
1
2022
76
0.180
Why?
Telemedicine
1
2023
119
0.180
Why?
Women's Rights
1
2021
2
0.180
Why?
National Institutes of Health (U.S.)
1
2021
25
0.180
Why?
Sleep Apnea, Obstructive
1
2022
64
0.180
Why?
Signal Processing, Computer-Assisted
2
1998
33
0.180
Why?
Angioplasty
1
2020
6
0.180
Why?
Peripheral Arterial Disease
1
2020
5
0.180
Why?
Weight Loss
1
2022
130
0.180
Why?
Health Expenditures
1
2020
18
0.180
Why?
Career Choice
1
2021
30
0.180
Why?
Heart Valve Diseases
1
2020
18
0.180
Why?
Physician-Patient Relations
1
2021
43
0.180
Why?
Disease Outbreaks
1
2021
82
0.180
Why?
Hyperlipidemias
1
2020
19
0.180
Why?
Postoperative Hemorrhage
1
2020
24
0.180
Why?
Periodicals as Topic
1
2021
43
0.180
Why?
Accidental Falls
1
2022
113
0.170
Why?
Myocardial Revascularization
1
2020
18
0.170
Why?
Endovascular Procedures
1
2020
34
0.170
Why?
Postnatal Care
1
2020
7
0.170
Why?
Delivery, Obstetric
1
2020
12
0.170
Why?
Radiation-Protective Agents
1
2020
3
0.170
Why?
Protective Factors
1
2020
26
0.170
Why?
Colchicine
1
2020
10
0.170
Why?
Social Class
1
2020
66
0.170
Why?
Odds Ratio
2
2020
268
0.170
Why?
Heart Valve Prosthesis Implantation
1
2020
28
0.170
Why?
Clinical Trials as Topic
1
2021
239
0.170
Why?
Infant, Newborn
1
2022
655
0.170
Why?
Income
1
2020
77
0.170
Why?
Prostatic Neoplasms
1
2021
104
0.170
Why?
Thrombolytic Therapy
1
2020
50
0.170
Why?
After-Hours Care
1
2019
1
0.170
Why?
Global Health
1
2019
42
0.170
Why?
Radiation Injuries
1
2020
32
0.160
Why?
Cardiac Resynchronization Therapy
1
2019
12
0.160
Why?
Health Behavior
1
2020
165
0.160
Why?
Up-Regulation
2
2021
177
0.160
Why?
Multimodal Imaging
1
2019
28
0.160
Why?
Heart
1
2019
68
0.160
Why?
Treatment Refusal
1
2018
11
0.160
Why?
Heart Transplantation
1
1998
30
0.150
Why?
Asia, Western
1
2018
2
0.150
Why?
Indian Ocean Islands
1
2018
2
0.150
Why?
Intensive Care Units
1
2021
301
0.150
Why?
Procainamide
1
1998
1
0.150
Why?
Surveys and Questionnaires
3
2022
1215
0.150
Why?
Reproducibility of Results
3
2017
733
0.150
Why?
Atrial Flutter
1
1998
5
0.150
Why?
Graft Rejection
1
1998
71
0.150
Why?
Tachycardia
2
2021
10
0.150
Why?
Walking
1
2020
259
0.150
Why?
Sulfonamides
1
1998
41
0.150
Why?
Memory Disorders
1
2019
162
0.150
Why?
Diagnosis, Differential
1
2019
372
0.150
Why?
Inpatients
1
2019
149
0.140
Why?
Coronary Disease
2
2020
66
0.140
Why?
Echocardiography
4
2023
114
0.140
Why?
Lupus Erythematosus, Systemic
1
2020
192
0.140
Why?
Diet Surveys
1
2017
25
0.140
Why?
Patient Discharge
1
2018
163
0.140
Why?
Evidence-Based Medicine
1
2018
196
0.140
Why?
Rivaroxaban
1
2016
5
0.140
Why?
Dabigatran
1
2016
5
0.140
Why?
Thiazoles
1
2016
19
0.140
Why?
Nutrition Assessment
1
2017
44
0.140
Why?
Pyridones
1
2016
11
0.140
Why?
Neoplasms
1
2020
239
0.140
Why?
Evidence-Based Practice
1
2017
85
0.140
Why?
Pyridines
1
2016
36
0.130
Why?
Patient Selection
2
2020
206
0.130
Why?
Coronary Vessels
2
2021
34
0.130
Why?
Sensitivity and Specificity
2
2015
517
0.130
Why?
Georgia
1
2016
11
0.130
Why?
Dementia
1
2022
573
0.130
Why?
Platelet Aggregation Inhibitors
1
2016
49
0.130
Why?
Cholesterol, LDL
1
2016
32
0.130
Why?
Pyrazoles
1
2016
58
0.130
Why?
Self Efficacy
1
2016
59
0.130
Why?
Health Surveys
1
2016
88
0.130
Why?
Equipment Design
2
2015
152
0.120
Why?
Miniaturization
1
2015
2
0.120
Why?
Chicago
2
2016
939
0.120
Why?
Diet, Mediterranean
1
2017
101
0.120
Why?
Preventive Health Services
1
2015
15
0.120
Why?
Heart Rate
2
2009
117
0.120
Why?
Equipment Failure Analysis
1
2015
108
0.120
Why?
Smoking
2
2018
176
0.110
Why?
Cardiac Pacing, Artificial
2
1992
22
0.110
Why?
Needs Assessment
1
2013
41
0.110
Why?
Drug Monitoring
1
2012
18
0.100
Why?
Heart Conduction System
1
1992
11
0.100
Why?
Data Collection
1
2012
98
0.100
Why?
Vascular Endothelial Growth Factor A
2
2024
71
0.100
Why?
Registries
3
2022
188
0.100
Why?
Activities of Daily Living
1
2016
608
0.100
Why?
Blood Pressure
2
2023
207
0.090
Why?
Motor Activity
1
2013
329
0.090
Why?
Coronary Artery Bypass
2
2020
29
0.080
Why?
Survival Rate
2
2019
356
0.070
Why?
Databases, Factual
2
2019
358
0.070
Why?
Severity of Illness Index
2
2021
985
0.070
Why?
Azetidines
1
2006
2
0.070
Why?
Benzylamines
1
2006
10
0.070
Why?
Time Factors
3
2021
1490
0.070
Why?
Body Mass Index
2
2020
465
0.060
Why?
Endpoint Determination
1
2004
22
0.060
Why?
Postoperative Complications
2
2020
931
0.050
Why?
Blood Pressure Monitoring, Ambulatory
1
2023
3
0.050
Why?
Brain-Derived Neurotrophic Factor
1
2024
48
0.050
Why?
Pharmacists
1
2023
19
0.050
Why?
Urokinase-Type Plasminogen Activator
1
2022
3
0.050
Why?
Follow-Up Studies
2
2019
1858
0.050
Why?
Receptors, Urokinase Plasminogen Activator
1
2022
22
0.050
Why?
Double-Blind Method
2
2006
432
0.050
Why?
Flecainide
1
2021
1
0.050
Why?
Genetic Testing
1
2022
59
0.050
Why?
Microcirculation
1
2021
29
0.050
Why?
Ischemia
1
2021
23
0.050
Why?
Delivery of Health Care
1
2023
154
0.050
Why?
Diuretics
1
2021
6
0.050
Why?
Pregnancy, High-Risk
1
2021
2
0.050
Why?
Peripartum Period
1
2021
3
0.050
Why?
Chlorides
1
2021
26
0.050
Why?
Recurrence
2
2006
322
0.050
Why?
Health Services Research
1
2021
42
0.040
Why?
Sodium
1
2021
64
0.040
Why?
Patient Preference
1
2021
33
0.040
Why?
Hypercholesterolemia
1
2020
27
0.040
Why?
Education, Medical
1
2021
45
0.040
Why?
Fetal Growth Retardation
1
2020
3
0.040
Why?
Polycystic Ovary Syndrome
1
2020
2
0.040
Why?
Lactation
1
2021
62
0.040
Why?
Menopause, Premature
1
2020
6
0.040
Why?
Abortion, Spontaneous
1
2020
5
0.040
Why?
Case-Control Studies
2
2000
593
0.040
Why?
Sleep Apnea, Central
1
2000
29
0.040
Why?
Clinical Decision-Making
1
2020
44
0.040
Why?
Health Care Costs
1
2020
80
0.040
Why?
Radiotherapy
1
2020
34
0.040
Why?
Attitude to Health
1
2020
105
0.040
Why?
Neuropsychological Tests
1
2024
1226
0.040
Why?
Curriculum
1
2021
164
0.040
Why?
Costs and Cost Analysis
1
2019
35
0.040
Why?
Autoimmune Diseases
1
2020
48
0.040
Why?
Thrombectomy
1
2019
31
0.040
Why?
Disease Management
1
2020
114
0.040
Why?
Cause of Death
1
2019
64
0.040
Why?
Multivariate Analysis
1
2020
331
0.040
Why?
Psychology
1
2018
23
0.040
Why?
Health Services Needs and Demand
1
2018
58
0.040
Why?
Heredity
1
2018
7
0.040
Why?
Cancer Survivors
1
2018
12
0.040
Why?
Diabetes Mellitus, Type 2
1
2020
191
0.040
Why?
Diet, Western
1
2017
11
0.030
Why?
Quality Improvement
1
2018
161
0.030
Why?
Breast Feeding
1
2018
169
0.030
Why?
Drug Therapy, Combination
1
2016
183
0.030
Why?
Waist Circumference
1
2015
35
0.030
Why?
Genetic Predisposition to Disease
1
2018
390
0.030
Why?
Risk
1
2016
205
0.030
Why?
Body Composition
1
2016
69
0.030
Why?
Decision Making
1
2018
226
0.030
Why?
Body Weight
1
2016
144
0.030
Why?
Patient Compliance
1
2016
164
0.030
Why?
Wolff-Parkinson-White Syndrome
1
1993
1
0.030
Why?
Dextroamphetamine
1
1993
2
0.030
Why?
Hypotension, Orthostatic
1
1993
11
0.030
Why?
Syncope
1
1993
4
0.030
Why?
Social Networking
1
2013
11
0.030
Why?
Efficiency
1
2013
20
0.030
Why?
Albuterol
1
1993
19
0.030
Why?
Bradycardia
1
1993
24
0.030
Why?
Interviews as Topic
1
2013
139
0.030
Why?
Program Evaluation
1
2013
137
0.030
Why?
Tachycardia, Ventricular
1
1992
23
0.030
Why?
Cardiac Catheterization
1
1992
72
0.020
Why?
Animals
1
2020
3780
0.020
Why?
Asthma
1
1993
162
0.020
Why?
Chemical and Drug Induced Liver Injury
1
2006
7
0.020
Why?
Estrogen Replacement Therapy
1
2006
19
0.020
Why?
Thromboembolism
1
2006
17
0.020
Why?
Chi-Square Distribution
1
2006
146
0.020
Why?
Proportional Hazards Models
1
2006
352
0.010
Why?
Combined Modality Therapy
1
2004
307
0.010
Why?
Electrocardiography, Ambulatory
1
2000
11
0.010
Why?
Bronchoscopy
1
2000
34
0.010
Why?
Tracheostomy
1
2000
27
0.010
Why?
Respiration
1
2000
35
0.010
Why?
Anesthesia
1
2000
31
0.010
Why?
Child
1
2000
1421
0.010
Why?
False Positive Reactions
1
1993
36
0.010
Why?
Contraindications
1
1993
33
0.010
Why?
Action Potentials
1
1993
89
0.010
Why?
Administration, Inhalation
1
1993
45
0.010
Why?
Posture
1
1993
66
0.010
Why?
ROC Curve
1
1992
144
0.010
Why?
Analysis of Variance
1
1992
269
0.010
Why?
Volgman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (370)
Explore
_
Co-Authors (34)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_